Methylation associated inactivation of RASSF1A and its synergistic effect with activated K-Ras in nasopharyngeal carcinoma

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Wang, Tao ^a   Liu, Hongli ^a   Chen, Yeshan ^a   Liu, Wei ^a   Yu, Jing ^b   Wu, Gang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; K RAS PROTEIN; LIPOSOME; PLASMID DNA; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RASSF1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE INACTIVATION; GENE TRANSFER; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; NASOPHARYNX; NASOPHARYNX CARCINOMA; PRIMARY TUMOR; PRIORITY JOURNAL; PROMOTER REGION; TUMOR BIOPSY; TUMOR SUPPRESSOR GENE; CARCINOMA; CELL SEPARATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; NASOPHARYNX TUMOR; ONCOGENE RAS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA; CELL SEPARATION; DNA METHYLATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, RAS; HUMANS; NASOPHARYNGEAL NEOPLASMS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEINS;

EID: 76149096516     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-160     Document Type: Article

References (39)

1. Aetiological factors and pathogenesis. DP Huang KW Lo, Nasopharyngeal Carcinoma Hong Kong: The Chinese University Press, van Hasselt GA, Gibb AG, 2 1999 31 60
2. Dietary risk factors for nasopharyngeal carcinoma in Maghrebian countries. BJ Feng M Jalbout WB Ayoub M Khyatti S Dahmoul M Ayad F Maachi W Bedadra M Abdoun S Mesli M Hamdi-Cherif K Boualga N Bouaouina L Chouchane A Benider F Ben Ayed D Goldgar M Corbex, Int J Cancer 2007 121 1550 1555 10.1002/ijc.22813 17582611
3. CpG island methylation and expression of tumour-associated genes in lung carcinoma. R Dammann M Strunnikova U Schagdarsurengin M Rastetter M Papritz UE Hattenhorst HS Hofmann RE Silber S Burdach G Hansen, Eur J Cancer 2005 41 8 1223 1236 10.1016/j.ejca.2005.02.020 15911247
4. Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma. J Geli P Kogner F Lanner N Natalishvili C Juhlin N Kiss GJ Clark TJ Ekström F Farnebo C Larsson, Int J Cancer 2008 123 2 389 394 10.1002/ijc.23533 18452173
5. Silent assassin: oncogenic ras directs epigenetic inactivation of target genes. X Cheng, Sci Signal 2008 1 e14 10.1126/stke.113pe14 18385037
6. Methylation of the Tumor Suppressor Gene RASSF1A in Human Tumors. GP Pfeifer R Dammann, Biochemistry 2005 70 576 583 15948711 (Pubitemid 40920802)
7. Aberrant methylation of p16, DLEC1, BLU and E-cadherin gene promoters in nasopharyngeal carcinoma biopsies from Tunisian patients. W Ayadi H Karray-Hakim A Khabir L Feki S Charfi T Boudawara A Ghorbel J Daoud M Frikha P Busson A Hammami, Anticancer Res 2008 28 4B 2161 7 18751390
8. Reduced expression of RASSF1A in esophageal and nasopharyngeal carcinomas significantly correlates with tumor stage. PH Lo D Xie KC Chan FP Xu I Kuzmin MI Lerman S Law D Chua J Sham ML Lung, Cancer Lett 2007 257 2 199 205 10.1016/j.canlet.2007.07.018 17720308
9. Inactivation of LARS2, located at the commonly deleted region 3p21.3, by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Wen Zhou Xiangling Feng Hong Li Lei Wang Bin Zhu Weidong Liu Ming Zhao Kaitai Yao Caiping Ren, Acta Biochim Biophys Sin (Shanghai). 2009 41 1 54 62 10.1093/abbs/gmn06 19129950
10. CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer. Z Liu J Zhao XF Chen W Li R Liu Z Lei X Liu X Peng K Xu J Chen H Liu QH Zhou HT Zhang, Lung Cancer 2008 62 1 15 22 10.1016/j.lungcan.2008.02.005 18358560
11. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. A Agathanggelou S Honorio DP Macartney A Martinez A Dallol J Rader, et al. Oncogene 2001 20 1509 1518 10.1038/sj.onc.1204175 11313894
12. Association of diminished expression of RASSF1A with promoter methylation in primary gastric cancer from patients of central China. M Ye B Xia Q Guo F Zhou X Zhang, BMC Cancer 2007 7 1 7 10.1186/1471-2407-7-1 17199887
13. Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma. K Steinmann A Sandner U Schagdarsurengin RH Dammann, Oncol Rep 2009 22 6 1519 26 19885608
14. RASSF1A mediates p21Cip1/Waf1-dependent cell cycle arrest and senescence through modulation of the Raf-MEK-ERK pathway and inhibition of Akt. S Thaler PS Hähnel A Schad R Dammann M Schuler, Cancer Res 2009 69 5 1748 57 10.1158/0008-5472.CAN-08-1377 19223555
15. 5-Aza-CdR regulates the expression of RASSF1A gene in human gastric cancer cell line and inhibits the growth of cells. WJ Shen DQ Dai Y Teng HB Liu, Zhonghua Wei Chang Wai Ke Za Zhi 2009 12 1 57 60 19145506
16. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County. WJ Xue C Li XJ Zhou HG Guan L Qin P Li ZW Wang HX Qian, J Gastroenterol Hepatol 2008 23 9 1448 58 10.1111/j.1440-1746.2007.05067.x 17683489
17. The RASSF1A Tumor Suppressor Activates Bax via MOAP-1. MD Vos A Dallol K Eckfeld NPC Allen H Donninger L Hesson, et al. The Journal of biological chemistry 2006 281 4557 4563 10.1074/jbc.M512128200 16344548
18. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. R Dammann C Li J-H Yoon PL Chin S Bates GP Pfeifer, Nature genetics 2000 25 315 319 10.1038/77083 10888881
19. Normal ras genes: their onco-suppressor and pro-apoptotic functions (review). DA Spandidos G Sourvinos C Tsatsanis A Zafiropoulos, Int J Oncol 2002 21 237 41 12118316
20. The Ras-association domain family (RASSF) members and their role in human tumourigenesis. L van der Weyden DJ Adams, Biochim Biophys Acta 2007 1776 1 58 85 17692468
21. Methylation-Specific Oligonucleotide Microarray: A New Potential for High-Throughput Methylation Analysis. RS Gitan H Shi C-M Chen PS Yan TH-M Huang, Genome Research 2007 12 158 164 10.1101/gr.202801
22. Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression. DG Burbee E Forgacs S Zöchbauer- Müller L Shivakumar K Fong B Gao, et al. Journal of the National Cancer Institute 2001 93 691 699 10.1093/jnci/93.9.691 11333291
23. Loss of Rassf1a cooperates with Apc(Min) to accelerate intestinal tumourigenesis. L van der Weyden MJ Arends Dovey OM Harrison HL Lefebvre G Conte N Gergely FV Bradley A DJ Adams, Oncogene 2008 27 4503 4508 10.1038/onc.2008.94 18391979
24. Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. A Agathanggelou WN Cooper F Latif, Cancer Res 2005 65 3497 508 10.1158/0008-5472.CAN-04-4088 15867337
25. RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma. LS-N Chow K-W Lo J Kwong K-F To K-S Tsang C-W Lam R Dammann DP Huang, Int J Cancer 2004 109 839 847 10.1002/ijc.20079 15027117
26. The RASSF1A tumor suppressor. H Donninger MD Vos GJ Clark, Journal of Cell Science 2007 120 3163 3172 10.1242/jcs.010389 17878233
27. The RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 Accumulation. L Shivakumar J Minna T Sakamaki R Pestell MA White, Molecular and Cellular biology 2002 22 4309 4318 10.1128/MCB.22.12.4309-4318. 2002 12024041
28. Activator protein-1 involved in growth inhibition by RASSF1A gene in the human gastric carcinoma cell line SGC7901. ZH Deng JF Wen JH Li DS Xiao JH Zhou, World J Gastroenterol 2008 14 1437 1443 10.3748/wjg.14.1437 18322962
29. Skp2 regulates the antiproliferative function of the tumor suppressor RASSF1A via ubiquitinmediated degradation at the G1-S transition. MS Song SJ Song SJ Kim K Nakayama KI Nakayama DS Lim, Oncogene 2008 27 3176 3185 10.1038/sj.onc.1210971 18071316
30. Dynamics of RASSF1A/MOAP-1 association with death receptors. CJ Foley H Freedman SL Choo C Onyskiw NY Fu VC Yu J Tuszynski JC Pratt S Baksh, Mol Cell Biol 2008 28 4520 4535 10.1128/MCB.02011-07 18474619
31. Signaling Specificity by Ras Family GTPases Is Determined by the Full Spectrum of Effectors They Regulate. P Rodriguez-Viciana C Sabatier F McCormick, Mol Cell Biol 2004 24 4943 4954 10.1128/MCB.24.11.4943-4954.2004 15143186
32. Ras Uses the Novel Tumor Suppressor RASSF1 as an Effector to Mediate Apoptosis. MD Vos CA Ellis A Bell MJ Birrer GJ Clark, The Journal of biological chemistry 2000 275 35669 35672 10.1074/jbc.C000463200 10998413
33. The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1. S Ortiz-Vegal A Khokhlatchev M Nedwidek X-F Zhang R Dammann GP Pfeifer, et al. Oncogene 2002 21 1381 1390 10.1038/sj.onc.1205192 11857081
34. RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor. MD Vos CA Ellis C Elam AS Ulku BJ Taylor GJ Clark, J Biol Chem 2003 278 28045 28051 10.1074/jbc.M300554200 12732644
35. ras Mutations are Uncommon in Nasopharyngeal Carcinoma. WCW Yung JST Sham DTK Choy MH Ng, Oral Oncol, Eur of cancer 1995 31B 399 400 10.1016/0964- 1955(95)00046-1
36. Frequent RASSF1A promoter hypermethylation and Kras mutations in pancreatic carcinoma. R Dammann U Schagdarsurengin L Liu N Otto O Gimm H Dralle BO Boehm GP Pfeifer C Hoang-Vu, Oncogene 2003 22 3806 3812 10.1038/sj.onc. 1206582 12802288
37. RASSF1A hypermethylation and its inverse correlation with BRAF and/or KRAS mutations in MSI-associated endometrial carcinoma. S Kang JM Lee ES Jeon S Lee H Kim HS Kim SS Seo SY Park D Sidransky SM Dong, Int J Cancer 2006 119 1316 1321 10.1002/ijc.21991 16619251
38. Evaluation of hypermethylated tumor suppressor genes as tumor markers in mouth and throat rinsing fluid, nasopharyngeal swab and peripheral blood of nasopharyngeal carcinoma patient. HW Chang A Chan DLW Kwong WI Wei JST Sham APW Yuen, Int J Cancer 2003 105 851 855 10.1002/ijc.11162 12767073 (Pubitemid 36706111)
39. Inactivation of RASSF1A, RARbeta2 and DAP-kinase by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma. A Fendri A Masmoudi A Khabir T Sellami-Boudawara J Daoud M Frikha A Ghorbel A Gargouri R Mokdad-Gargouri, Cancer Bio Ther 2009 8 5 444 51